2010
DOI: 10.1038/nbt.1629
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells

Abstract: Human embryonic stem cells (hESCs) have two properties of interest for the development of cell therapies: self-renewal and the potential to differentiate into all major lineages of somatic cells in the human body. Widespread clinical application of hESC-derived cells will require culture methods that are low-cost, robust, scalable and use chemically defined raw materials. Here we describe synthetic peptide-acrylate surfaces (PAS) that support self-renewal of hESCs in chemically defined, xeno-free medium. H1 an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

8
389
0
1

Year Published

2011
2011
2016
2016

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 418 publications
(399 citation statements)
references
References 21 publications
8
389
0
1
Order By: Relevance
“…We therefore evaluated surfaces displaying a cyclic RGD-containing peptide (cRGD) known to interact with high affinity with the α V β 3 and α V β 5 integrins (21). Additionally, we assessed RGD-containing peptides derived from bone sialoprotein [BSP(RGD)] (26) and vitronectin [VTN(RGD)] (22). We included a laminin-derived ligand for integrin α V β 3 and α 5 β 1 (C-16) (27) and a cyclic peptide integrin α 5 β 1 ligand (CRRETAWAC) (28).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We therefore evaluated surfaces displaying a cyclic RGD-containing peptide (cRGD) known to interact with high affinity with the α V β 3 and α V β 5 integrins (21). Additionally, we assessed RGD-containing peptides derived from bone sialoprotein [BSP(RGD)] (26) and vitronectin [VTN(RGD)] (22). We included a laminin-derived ligand for integrin α V β 3 and α 5 β 1 (C-16) (27) and a cyclic peptide integrin α 5 β 1 ligand (CRRETAWAC) (28).…”
Section: Resultsmentioning
confidence: 99%
“…Such defined substrata have been developed for the long-term culture of undifferentiated hPS cells in defined media. A number of surfaces have been described including recombinant proteins (14)(15)(16), fully synthetic polymers (17)(18)(19), and peptide-modified surfaces (20)(21)(22)(23). Surfaces that present bioactive peptides have the advantage that they can be programmed to interact with specific cell-surface macromolecules such as the glycosaminoglycans (GAGs) and integrins.…”
mentioning
confidence: 99%
“…Here, we develop a technology that notably provides expansion rates greater than the gold standard of feeder substrates; works with enzymatic passaging; and is compatible with current manipulations involving hESCs/hiPSCs, including gene modification and reprogramming. Importantly, in contrast to the previous reports that used polymers and/or peptides to coat the dish (10)(11)(12)14), our UV/ozone (UV) treatment of common research materials is an attractive alternative because it is inexpensive and mass production of appropriately treated culture dishes for numerous applications should be straightforward.…”
mentioning
confidence: 92%
“…A variety of substrates are used in these methods: synthetic polymers (11,14), peptide-modified surfaces (10,12), embryonic ECM laminin isoforms (7), fibronectin from ECM with a small molecule mixture (9), and various vitronectin proteins (4,6). Some of these culture methods use animal products, which makes potential transplantation applications problematic (21).…”
mentioning
confidence: 99%
See 1 more Smart Citation